Letter: Efficacy and Safety of Dupilumab in Pediatric Atopic Dermatitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Dermatitis® · 15.07.2026
DOI: 10.1177/17103568261470925 ↗Kurz gefasst
Leserbrief in der Zeitschrift Dermatitis®, online erschienen am 15.07.2026. Verfasst von Sana Gupta und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, University of Ottawa, Ottawa, Canada. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Faculty of Medicine, University of Ottawa, Ottawa, Canada.
- Department of Medicine, Division of Dermatology, University of Toronto, Toronto, Canada.
- Department of Medicine, Division of Dermatology, Women's College Hospital, Toronto, Canada.
ORCID-Profile: Sana Gupta
Zitieren
APA
Gupta, S., Bai, J. Q. A., & Mukovozov, I. (2026). Letter: Efficacy and Safety of Dupilumab in Pediatric Atopic Dermatitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Dermatitis®. https://doi.org/10.1177/17103568261470925
Vancouver
Gupta S, Bai JQA, Mukovozov I. Letter: Efficacy and Safety of Dupilumab in Pediatric Atopic Dermatitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Dermatitis®. 2026. doi:10.1177/17103568261470925
BibTeX
@article{Gupta2026,
author = {Gupta, Sana and Bai, Jia Qi Adam and Mukovozov, Ilya},
title = {Letter: Efficacy and Safety of Dupilumab in Pediatric Atopic Dermatitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials},
journal = {Dermatitis®},
year = {2026},
doi = {10.1177/17103568261470925}
}
EUVIMED